Latest Industry Projects

DAIICHI SANKYO AND RANBAXY TO EXPAND BUSINESS OF BOTH COMPANIES in BRAZIL

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and Ranbaxy Laboratories Limited (hereafter, Ranbaxy) today announced synergy in Brazil to expand the business of both companies in the country. As part of this synergy, Ranbaxy will support Daiichi Sankyo’s Brazilian subsidiary, Daiichi Sankyo Brasil Farmaceutica Ltda. (hereafter, Daiichi Sankyo Brazil), to enter the branded generics market, in addition to its established business of providing innovative products. Ranbaxy’s Brazilian subsidiary, Ranbaxy Farmaceutica Ltda. (hereafter, RFL) would continue to independently promote Ranbaxy’s generic products and also enter into branded generics in Brazil. The pharmaceutical market in Brazil is the biggest in Latin America, and it is expected to become the fourth biggest in the world in 2016. In Brazil, Daiichi Sankyo has built up its market presence with innovative pharmaceuticals through Daiichi Sankyo Brazil. On the other hand, Ranbaxy markets its generic products in Brazil through its subsidiary, Ranbaxy Farmaceutica Ltda. With the announced synergistic collaboration, the Daiichi Sankyo Group will expand its presence in Brazil through its hybrid business model promoting innovative, branded generic and generic pharmaceuticals. About Daiichi Sankyo Brasil Farmaceutica Ltda. Founded: 1962 Head Office: Sao Paulo, Brazil Representative: Eloi Bosio Sales: 6.7 billion yen ($85 Mn*) (FY 2011) Employee: 314 (December 2012) Main Products: Benicar®, Effient® *79.07 yen/$ About Ranbaxy Farmaceutica Ltda. Founded: 1999 Head Office: Sao Paulo, Brazil Representative: Alok Kapoor Sales: $20.5 million (FY 2012) Employee: 72 (December 2012) Products: Generics http://www.ranbaxy.com/daiichi-sankyo-and-ranbaxy-launch-hybrid-business-in-brazil-to-expand-business-of-both-companies/ Project Name DAIICHI SANKYO AND RANBAXY TO EXPAND BUSINESS OF BOTH COMPANIES in BRAZIL Location Brazil Commence 2013 Completion 2016 Estimated Investment -NA- Capacity -NA- Key Players Ranbaxy and Daiichi Sankyo

Other Projects